151 related articles for article (PubMed ID: 23175437)
1. Brucine induces the apoptosis of U266 multiple myeloma cells by phosphorylation of c-Jun.
Ma Y; Li Z; Wang Y; Feng J
Mol Med Rep; 2013 Feb; 7(2):481-4. PubMed ID: 23175437
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species-mediated activation of AMP-activated protein kinase and c-Jun N-terminal kinase plays a critical role in beta-sitosterol-induced apoptosis in multiple myeloma U266 cells.
Sook SH; Lee HJ; Kim JH; Sohn EJ; Jung JH; Kim B; Kim JH; Jeong SJ; Kim SH
Phytother Res; 2014 Mar; 28(3):387-94. PubMed ID: 23640957
[TBL] [Abstract][Full Text] [Related]
3. Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell lines.
Hideshima T; Hayashi T; Chauhan D; Akiyama M; Richardson P; Anderson K
Oncogene; 2003 Nov; 22(54):8797-801. PubMed ID: 14647474
[TBL] [Abstract][Full Text] [Related]
4. [Effect of brucine on metabolism of osteoblasts and osteoclasts in multiple myeloma].
Wang YH; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):399-403. PubMed ID: 21518496
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
Que W; Chen J; Chuang M; Jiang D
APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.
Kim BK; Kim HM; Chung KS; Kim DM; Park SK; Song A; Won KJ; Lee K; Oh YK; Lee K; Song KB; Simon JA; Han G; Won M
Carcinogenesis; 2011 Mar; 32(3):254-61. PubMed ID: 21084431
[TBL] [Abstract][Full Text] [Related]
7. The cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7221 cells.
Yin W; Deng XK; Yin FZ; Zhang XC; Cai BC
Food Chem Toxicol; 2007 Sep; 45(9):1700-8. PubMed ID: 17449162
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 20 (S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266].
Song Y; Hou J; Kang L; Gao S
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):519-23. PubMed ID: 24985176
[TBL] [Abstract][Full Text] [Related]
9. Effects of brucine on bone metabolism in multiple myeloma.
Ma Y; Zhao J; Wang Y; Li Z; Feng J; Ren H
Mol Med Rep; 2012 Aug; 6(2):367-70. PubMed ID: 22614932
[TBL] [Abstract][Full Text] [Related]
10. [Impact of PTEN gene knockout in human breast carcinoma MCF-7 cells on activity of JNK pathway].
Jin Y; Hu JL; Xiao L; Cui W
Ai Zheng; 2008 Dec; 27(12):1239-43. PubMed ID: 19079986
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
[TBL] [Abstract][Full Text] [Related]
12. [Inducing-apoptosis effect of brucine on human monocytic leukemia cell line THP-1 and its mechanism].
Xin F; Wei W; Ji AF; Shen XL; Zhang GX; Zhang MX; Li XX; Zhang HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):681-6. PubMed ID: 24989276
[TBL] [Abstract][Full Text] [Related]
13. 4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces apoptosis in multiple myeloma cells through the IL-6 signal transduction pathway and increases FOXO3a-Bim expression.
Shen JK; Du HP; Ma Q; Yang M; Wang YG; Jin J
Oncol Rep; 2013 Jul; 30(1):425-32. PubMed ID: 23624712
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis.
Deng R; Li W; Guan Z; Zhou JM; Wang Y; Mei YP; Li MT; Feng GK; Huang W; Liu ZC; Han Y; Zeng YX; Zhu XF
Oncogene; 2006 Nov; 25(53):7070-7. PubMed ID: 16715131
[TBL] [Abstract][Full Text] [Related]
15. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism.
Deng XK; Yin W; Li WD; Yin FZ; Lu XY; Zhang XC; Hua ZC; Cai BC
J Ethnopharmacol; 2006 Jun; 106(2):179-86. PubMed ID: 16442763
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway.
Gao Y; Signore AP; Yin W; Cao G; Yin XM; Sun F; Luo Y; Graham SH; Chen J
J Cereb Blood Flow Metab; 2005 Jun; 25(6):694-712. PubMed ID: 15716857
[TBL] [Abstract][Full Text] [Related]
17. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
18. The apoptotic effect of brucine from the seed of Strychnos nux-vomica on human hepatoma cells is mediated via Bcl-2 and Ca2+ involved mitochondrial pathway.
Deng X; Yin F; Lu X; Cai B; Yin W
Toxicol Sci; 2006 May; 91(1):59-69. PubMed ID: 16443926
[TBL] [Abstract][Full Text] [Related]
19. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
20. Polyphyllin D induces apoptosis in U87 human glioma cells through the c-Jun NH2-terminal kinase pathway.
Yu Q; Li Q; Lu P; Chen Q
J Med Food; 2014 Sep; 17(9):1036-42. PubMed ID: 25045920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
